CAMBRIDGE, Mass., July 11, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq:CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that management will be attending the William Blair Biotech Focus Conference 2022 in New York City. Codiak’s Chief Executive Officer, Douglas E. Williams, Ph.D., will participate in a panel discussion entitled “Developing Therapies for the Next Immuno-Oncology Targets,” on Tuesday, July 12 from 4:10 - 5:20 pm ET and the Company will also be hosting one-on-one meetings at the conference.
Read more at globenewswire.comCodiak BioSciences to Participate at William Blair Biotech Focus Conference 2022
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/AI%20(artificial%20intelligence)/Data%20Center%20by%20Caureem%20via%20Shutterstock%20(2).jpg)
/PayPal%20Holdings%20Inc%20HQ%20photo-by%20bennymarty%20via%20iStock.jpg)
/Micron%20Technology%20Inc_%20logo%20on%20building-by%20vzphotos%20vis%20iStock.jpg)
